Psychosocial risk and health care utilization in pediatric sickle cell disease

Kerri E Woodward1,2, Yelena L Johnson1,2, Lindsey L Cohen3

  • 1Aflac Cancer and Blood Disorders Center, Children's Health care of Atlanta, Atlanta, Georgia, USA.

Insights

Psychosocial screening in pediatric sickle cell disease (SCD) identifies families at higher risk for increased healthcare use. The Psychosocial Assessment Tool (PAT) can help tailor support for these children and families.

Area of Science:

  • Pediatric Hematology
  • Psychosocial Medicine
  • Healthcare Management

Background:

  • Sickle cell disease (SCD) in children leads to significant pain and complications, resulting in high healthcare utilization.
  • Psychosocial screening is crucial for identifying at-risk families in chronic pediatric conditions to optimize care and resource allocation.

Purpose of the Study:

  • To evaluate the effectiveness of psychosocial screening in predicting increased healthcare utilization among pediatric patients with SCD.
  • To determine if psychosocial risk status modifies the relationship between pain frequency and healthcare utilization in youth with SCD.

Main Methods:

  • A cohort of 74 pediatric patients (8-18 years) with SCD and their parents were recruited from specialized clinics.
  • Parents completed the Psychosocial Assessment Tool (PAT) to categorize family risk (Universal, Targeted, Clinical).
  • Pain frequency was self-reported by youth, and healthcare utilization was extracted from medical records. ANOVA and moderation analyses were used.

Main Results:

  • Families were classified as Universal (56.8%), Targeted (29.7%), or Clinical (13.5%) risk.
  • Patients in the Targeted risk group reported significantly higher pain frequency compared to the Universal group.
  • Clinical psychosocial risk significantly amplified the association between pain frequency and healthcare utilization.

Conclusions:

  • The Psychosocial Assessment Tool (PAT) can identify families with elevated distress and predict higher healthcare utilization in pediatric sickle cell disease.
  • Integrating PAT into routine care can help providers identify families needing enhanced psychosocial or medical support.
  • This approach can optimize the management of sickle cell disease by addressing psychosocial factors impacting healthcare needs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
71
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
156
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
256
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
58
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
682